abatacept 125 mg, administered once per week (without an iv. loading dose), or adalimumab 40 mg administered sc. every other week, both given in combination with MTX. The trial was single blind ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback